Evidence map›Paper›PMID 38507797›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Evaluation of Malaria Rapid Diagnostic Test Performance and pfhrp2 Deletion in Tanzania School Surveys, 2017.

Billy Ngasala, Frank Chacky, Ally Mohamed, Fabrizio Molteni, Ssanyu Nyinondi, Bilali Kabula, Humphrey Mkali, Kyaw Thwai, Zachary R Popkin-Hall, Cedar Mitchell and 3 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Billy NgasalaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Frank ChackyNational Malaria Control Programme, Dodoma, Tanzania.
Ally MohamedNational Malaria Control Programme, Dodoma, Tanzania.
Fabrizio MolteniSwiss Tropical and Public Health Institute, Basel, Switzerland.
Ssanyu NyinondiRTI International, Dar es Salaam, Tanzania.
Bilali KabulaRTI International, Dar es Salaam, Tanzania.
Humphrey MkaliRTI International, Dar es Salaam, Tanzania.
Kyaw ThwaiInstitute for Global health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Zachary R Popkin-HallInstitute for Global health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Cedar MitchellInstitute for Global health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Jonathan B ParrInstitute for Global health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Jonathan J JulianoInstitute for Global health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Jessica T LinInstitute for Global health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
University of North Carolina at Chapel Hill · USPlan International Tanzania · TZAfrican Malaria Network Trust · TZMuhimbili University of Health and Allied Sciences · TZSwiss Tropical and Public Health Institute · CH

Funding

Determinants of malaria transmission by submicroscopic gametocytemiaR01AI137395 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, JESSICA · 2018 to 2022
$3.3M
Mentoring in Translational Malaria GenomicsK24AI134990 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan J Juliano · 2018 to 2026
$1.6M
Does treating low density malaria infections reduce malaria transmission?R03AI173899 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, JESSICA · 2023 to 2024
$156k
NIAID NIH HHS K24 AI134990NIAID NIH HHS R01 AI137395NIAID NIH HHS R03 AI173899
6 · The paper itself

Abstract

As part of malaria nationwide monitoring and evaluation initiatives, there is an increasing trend of incorporating malaria rapid diagnostic tests (mRDTs) in surveys conducted within primary schools to detect malaria parasites. However, mRDTs based on the detection of histidine-rich protein 2 (HRP2) are known to yield false-positive results due to persistent antigenemia, and false-negative results may result from low parasitemia or Plasmodium falciparum hrp2/3 gene deletion. We evaluated diagnostic performance of an HRP2 and pan-parasite lactate dehydrogenase (HRP2/pLDH) mRDT against polymerase chain reaction (PCR) for detection of P. falciparum among 17,051 primary school-age children from eight regions of Tanzania in 2017. According to PCR, the prevalence of P. falciparum was 19.2% (95% CI: 18.6-19.8). Using PCR as reference, the sensitivity and specificity of mRDT was 76.2% (95% CI: 74.7-77.7) and 93.9% (95% CI: 93.5-94.3), respectively. Test agreement was lowest in low transmission areas, where true-positive mRDTs were outnumbered by false-negatives due to low parasitemia. Discordant samples (mRDT-negative but PCR-positive) were screened for pfhrp2/3 deletion by real-time PCR. Among those with a parasite density sufficient for analysis, pfhrp2 deletion was confirmed in 60 samples, whereas pfhrp3 deletion was confirmed in two samples; one sample had both pfhrp2 and pfhrp3 deletions. The majority of samples with gene deletions were detected in the high-transmission Kagera region. Compared with mRDTs, PCR and other molecular methods offer increased sensitivity and are not affected by pfhrp2/3 deletions, making them a useful supplement to mRDTs in schools and other epidemiological surveys.

Indexed as

Antigens, ProtozoanMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsChildFemaleGene DeletionHumansMalePolymerase Chain ReactionPrevalenceRapid Diagnostic TestsSchoolsSensitivity and SpecificityTanzaniaAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID38507797
PMCPMC11066367
OpenAlexW4394765862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.